Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution. - Wikidata - awgldk - TriplyDB

Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

http://www.wikidata.org/entity/Q33431708

about

Temporality of heparin-induced antibodies: a retrospective study in outpatients undergoing hemodialysis on unfractionated heparin

P2860

Q58741558-5721AD16-1022-4258-8551-1746DEFDDA4F

P2860

Screening frequency, incidence and pattern of heparin-induced thrombocytopenia syndrome at a large tertiary institution.

http://www.wikidata.org/entity/Q33431708

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Screening frequency, incidence ...... a large tertiary institution.

@ast

Screening frequency, incidence ...... a large tertiary institution.

@en

type

label

Screening frequency, incidence ...... a large tertiary institution.

@ast

Screening frequency, incidence ...... a large tertiary institution.

@en

prefLabel

Screening frequency, incidence ...... a large tertiary institution.

@ast

Screening frequency, incidence ...... a large tertiary institution.

@en

P1433

Q33431708-83964ADD-2F7A-45DB-9335-3FC43707302C

P1476

Q33431708-EBBBE32C-4DEE-4B64-94FA-393EF60A6466

P2093

Q33431708-25250CE7-02C4-410B-8D74-4D947485695E

Q33431708-265EFEAE-72ED-4E54-9D88-42324B8DFCD9

Q33431708-4575543F-81C8-4DBF-97FB-D187B7646BA9

Q33431708-6199FEA6-F1F6-41D8-8B9C-6F1279F453F8

Q33431708-6E4FCF4B-D516-4F11-A720-F5B3E047DD27

Q33431708-71D9D407-A30B-4BC6-AE65-4E4E5E979BB7

Q33431708-7F4A6FAF-5438-4399-B282-F306F150E5D8

Q33431708-C77F8AE3-2026-426F-8DCA-87C5D3E9FA16

Q33431708-FF88452F-B504-4921-80F5-7501D155E961

P2860

Q33431708-109A3304-F8CB-47AE-A2EF-B0EBF651F65B

Q33431708-1C6C6C53-AEED-47AE-8E17-4EC7CAF454CC

Q33431708-25593493-1ED3-4373-9B41-3A6969EA478C

Q33431708-26BB3F7C-D1AD-4A6A-8659-2C923E5183CB

Q33431708-28361386-2FC5-483B-BF9F-7890D3955733

Q33431708-286FE28F-0BB7-4043-BF24-F92C9E9695A3

Q33431708-36238E6F-76C5-4B33-B64A-4EE5DDC25C34

Q33431708-3F75800A-FDDE-4AA3-BDD9-971FA7FE902A

Q33431708-528C6D43-6708-4FEA-9C21-113975E66295

Q33431708-541E0241-7271-433D-9DD6-D05501517BA2

P2888

Q33431708-624AC95B-07B4-4E19-902F-ADB999642E4D

P304

Q33431708-2EAC1944-CA73-4BCF-95E0-B93131BD0892

P31

Q33431708-74AC5A3F-9555-468F-AAEA-8801884EC961

P356

Q33431708-FBF3D635-358F-41C0-B526-0AAE779FF53C

P433

Q33431708-E3430318-3F72-4624-B2CB-AB8B369831BF

P478

Q33431708-7229E58A-BB7F-45B1-971A-B9B627DAC589

P577

Q33431708-93358D45-8DB0-4F59-A129-4488642B48D9

P6179

Q33431708-B99CAA2D-F01B-401C-9615-C7D6AA2FCEEB

P698

Q33431708-33DAF43E-384D-4164-85DC-4EDB07F5C32E

P921

Q33431708-8C408122-4189-47D0-B938-76EEE801B755

P356

S12185-016-2013-3

P1433

International Journal of Hematology

P1476

Screening frequency, incidence ...... a large tertiary institution.

@en

P2093

Cynthia Ciwei Lim

http://www.w3.org/2001/XMLSchema#string

Hae Tha Mya

http://www.w3.org/2001/XMLSchema#string

Heng Joo Ng

http://www.w3.org/2001/XMLSchema#string

Hui Ming Tay

http://www.w3.org/2001/XMLSchema#string

HuiLin Choong

http://www.w3.org/2001/XMLSchema#string

Lai Heng Lee

http://www.w3.org/2001/XMLSchema#string

Shien Wen Gan

http://www.w3.org/2001/XMLSchema#string

Shilpa Surendran

http://www.w3.org/2001/XMLSchema#string

Shu Hui Yeang

http://www.w3.org/2001/XMLSchema#string

P2860

Rates of clinically apparent heparin-induced thrombocytopenia for unfractionated heparin vs. low molecular weight heparin in non-surgical patients are low and similar.

Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia.

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study.

Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.

The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.

Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.

Role of platelet surface PF4 antigenic complexes in heparin-induced thrombocytopenia pathogenesis: diagnostic and therapeutic implications.

Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need?

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings.

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.

P2888

s12185-016-2013-3

P304

92-98

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12185-016-2013-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1034677437

http://www.w3.org/2001/XMLSchema#string

P698

27106479

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia